1-5 of 5
Kenjiro Sawada
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract A16: The potential of circulating cell-free tumor DNA as a diagnostic marker of ovarian cancer

Free
Misa Yamamoto, Kenjiro Sawada, Aasa Shimizu, Yuri Matsumoto, Michiko Kodama, Kae Hashimoto, Tadashi Kimura
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (11_Supplement): A16.
https://doi.org/10.1158/1557-3265.LiqBiop20-A16
Published: 01 June 2020
View articletitled, Abstract A16: The potential of circulating cell-free tumor DNA as a diagnostic marker of ovarian cancer
Journal Articles

The Highly Metastatic Nature of Uterine Cervical/Endometrial Cancer Displaying Tumor-Related Leukocytosis: Clinical and Preclinical Investigations

Available to Purchase
Tomoyuki Sasano, Seiji Mabuchi, Katsumi Kozasa, Hiromasa Kuroda, Mahiru Kawano, Ryoko Takahashi, Naoko Komura, Eriko Yokoi, Yuri Matsumoto, Kae Hashimoto, Kenjiro Sawada, Eiichi Morii, Tadashi Kimura
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (16): 4018–4029.
https://doi.org/10.1158/1078-0432.CCR-17-2472
Published: 14 August 2018
View articletitled, The Highly Metastatic Nature of Uterine Cervical/Endometrial Cancer Displaying Tumor-Related Leukocytosis: Clinical and Preclinical Investigations
Open the PDF for The Highly Metastatic Nature of Uterine Cervical/Endometrial Cancer Displaying Tumor-Related Leukocytosis: Clinical and Preclinical Investigations in another window
Includes: Supplementary data
Journal Articles

The Activity of Trabectedin As a Single Agent or in Combination with Everolimus for Clear Cell Carcinoma of the Ovary

Available to Purchase
Seiji Mabuchi, Takeshi Hisamatsu, Chiaki Kawase, Masami Hayashi, Kenjiro Sawada, Kazuya Mimura, Kazuhiro Takahashi, Toshifumi Takahashi, Hirohisa Kurachi, Tadashi Kimura
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (13): 4462–4473.
https://doi.org/10.1158/1078-0432.CCR-10-2987
Published: 05 July 2011
View articletitled, The Activity of Trabectedin As a Single Agent or in Combination with Everolimus for Clear Cell Carcinoma of the Ovary
Open the PDF for The Activity of Trabectedin As a Single Agent or in Combination with Everolimus for Clear Cell Carcinoma of the Ovary in another window
Includes: Supplementary data
Journal Articles

Foretinib (GSK1363089), an Orally Available Multikinase Inhibitor of c-Met and VEGFR-2, Blocks Proliferation, Induces Anoikis, and Impairs Ovarian Cancer Metastasis

Available to Purchase
Marion Zillhardt, Sun-Mi Park, Iris L. Romero, Kenjiro Sawada, Anthony Montag, Thomas Krausz, S. Diane Yamada, Marcus E. Peter, Ernst Lengyel
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (12): 4042–4051.
https://doi.org/10.1158/1078-0432.CCR-10-3387
Published: 15 June 2011
View articletitled, Foretinib (GSK1363089), an Orally Available Multikinase Inhibitor of c-Met and VEGFR-2, Blocks Proliferation, Induces Anoikis, and Impairs Ovarian Cancer Metastasis
Open the PDF for Foretinib (GSK1363089), an Orally Available Multikinase Inhibitor of c-Met and VEGFR-2, Blocks Proliferation, Induces Anoikis, and Impairs Ovarian Cancer Metastasis in another window
Includes: Supplementary data
Journal Articles

mTOR Is a Promising Therapeutic Target Both in Cisplatin-Sensitive and Cisplatin-Resistant Clear Cell Carcinoma of the Ovary

Available to Purchase
Seiji Mabuchi, Chiaki Kawase, Deborah A. Altomare, Kenichirou Morishige, Kenjiro Sawada, Masami Hayashi, Masahiko Tsujimoto, Mareo Yamoto, Andres J. Klein-Szanto, Russell J. Schilder, Masahide Ohmichi, Joseph R. Testa, Tadashi Kimura
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (17): 5404–5413.
https://doi.org/10.1158/1078-0432.CCR-09-0365
Published: 31 August 2009
View articletitled, mTOR Is a Promising Therapeutic Target Both in Cisplatin-Sensitive and Cisplatin-Resistant Clear Cell Carcinoma of the Ovary
Open the PDF for mTOR Is a Promising Therapeutic Target Both in Cisplatin-Sensitive and Cisplatin-Resistant Clear Cell Carcinoma of the Ovary in another window